# Dexmedetomidine Infusion on Intraoperative Propofol,Fentanyl Requirements in Spine Surgery for Pediatric Cancer Patients

> **NCT05493228** · PHASE3 · UNKNOWN · sponsor: **Children's Cancer Hospital Egypt 57357** · enrollment: 38 (estimated)

## Conditions studied

- Spine Cancer
- Anesthesia

## Interventions

- **DRUG:** Precedex Injectable Product
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT05493228
- **Lead sponsor:** Children's Cancer Hospital Egypt 57357
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-17
- **Primary completion:** 2023-04-17
- **Final completion:** 2023-10-30
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2022-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05493228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05493228, "Dexmedetomidine Infusion on Intraoperative Propofol,Fentanyl Requirements in Spine Surgery for Pediatric Cancer Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05493228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*